CSL Team Cycles to Support Alpha-1 Foundation, Highlighting Patient Determination
Table of Contents
A team from CSL Plasma recently participated in a cycling trek to raise awareness and funds for the Alpha-1 Foundation, demonstrating a commitment to supporting individuals affected by Alpha-1 antitrypsin deficiency (Alpha-1). The event showcased the resilience and determination of Alpha-1 patients, with participants cycling significant distances despite the challenges posed by the condition, which often leads to lung and liver disease.
Understanding Alpha-1 Antitrypsin Deficiency
Alpha-1 is a genetic disorder that can cause severe lung disease, including emphysema, and liver disease. It’s caused by a deficiency of the Alpha-1 antitrypsin protein, which protects the lungs and liver from damaging enzymes.
CSL’s Commitment and the Cycling Trek
The CSL team’s participation in the cycling trek underscores the company’s dedication to the Alpha-1 community. Participants cycled varying distances, with some requiring assistive oxygen due to the lung complications associated with Alpha-1.
Phil Klara, Associate Director in Product marketing at CSL, emphasized the importance of the event for fostering connection within the Alpha-1 community. “Alpha-1 too frequently enough leads to reduced lung function with limited activity, but this group of Alphas remain determined to make a difference and change the course of disease,” he said. He also highlighted the importance of remembering those who have lived with the condition before, while expressing optimism for future advancements.
inspirational Stories from Participants
The trek was particularly inspiring due to the participation of Alpha-1 patients themselves.Dee, an Alpha-1 patient, cycled an impressive 103 miles, demonstrating remarkable perseverance. “Having Alpha 1 has slowed me down but,I guess it’s in my nature to not let it stop me,” she stated,adding,”I rode not just for myself but for all Alpha patients.”
Emma Hatcher, CSL’s Director of U.S. Advocacy, noted the event’s value in connecting with patients and witnessing the Alpha-1 Foundation’s work firsthand. “This event gives us the opportunity to connect with patients on a personal level and to see the Alpha-1 Foundation in action-working every day on behalf of the community,” she said.
Supporting the Alpha-1 Foundation
The Alpha-1 Foundation plays a crucial role in funding research,providing support services,and advocating for individuals with alpha-1.
Key takeaways:
* Alpha-1 antitrypsin deficiency is a genetic disorder impacting the lungs and liver.
* CSL Plasma actively supports the Alpha-1 Foundation through fundraising and awareness initiatives.
* alpha-1 patients demonstrate amazing resilience and determination in the face of health challenges.
* The Alpha-1 Foundation provides critical resources and advocacy for the Alpha-1 community.
The CSL team’s participation in this cycling trek serves as a powerful reminder of the importance of community support and the ongoing need for research and advancements in the treatment of Alpha-1. Continued collaboration between pharmaceutical companies, foundations, and patients will be essential in improving the lives of those affected by this challenging condition.
Worth a look